__timestamp | BeiGene, Ltd. | GSK plc |
---|---|---|
Wednesday, January 1, 2014 | 13035000 | 23006000000 |
Thursday, January 1, 2015 | 8816000 | 23923000000 |
Friday, January 1, 2016 | 1070000 | 27889000000 |
Sunday, January 1, 2017 | 238387000 | 30186000000 |
Monday, January 1, 2018 | 198220000 | 30821000000 |
Tuesday, January 1, 2019 | 428212000 | 33754000000 |
Wednesday, January 1, 2020 | 308874000 | 34099000000 |
Friday, January 1, 2021 | 1176283000 | 34114000000 |
Saturday, January 1, 2022 | 1415921000 | 29324000000 |
Sunday, January 1, 2023 | 2458779000 | 30328000000 |
Infusing magic into the data realm
In the ever-evolving landscape of the pharmaceutical industry, GSK plc and BeiGene, Ltd. stand as titans with contrasting trajectories. Over the past decade, GSK has consistently demonstrated robust revenue growth, peaking at approximately $30 billion annually. In contrast, BeiGene, Ltd., a rising star, has seen its revenue skyrocket by over 18,000% from 2014 to 2023, reflecting its aggressive expansion and innovation strategy.
GSK's revenue has remained relatively stable, with a slight dip in 2022, while BeiGene's revenue surged, particularly from 2021 onwards, reaching nearly $2.5 billion in 2023. This growth underscores BeiGene's increasing influence in the global market, driven by its focus on oncology and biotechnology.
As these companies continue to navigate the complexities of the pharmaceutical world, their financial trajectories offer a fascinating glimpse into the industry's future.
Comparison of R&D Expenses for Pfizer and AstraZeneca in 2023
Annual Comparison of SG&A Expense Ratio for AstraZeneca, Pfizer, and GlaxoSmithKline
5 Year Trend in Average Market Capitalization for AbbVie
Comparison of R&D Expenses for Pfizer and AstraZeneca in 2023
Comparison of Average SG&A Expense Ratio for AstraZeneca, Pfizer, and GlaxoSmithKline Over the Years
Comparison of Average SG&A Expense Ratio for AstraZeneca, Pfizer, and GlaxoSmithKline Over the Years
Number of Employees for Top 10 Healthcare Companies
Number of Employees for Top 10 Pharma Companies
Average Market Capitalization of Abbvie Annually
5 Year Trend in Market Capitalization for AbbVie
5 Year Trend in Average Market Capitalization for AbbVie
Comparison of Net Income Margin for Glaxosmithkline, AstraZeneca, Takeda, and Eli Lilly Over the Last 8 Quarters